India’s Generic Pharma Boom: What’s Next for the Industry?
Valued at $50 billion, the Indian pharmaceutical sector continues to grow, fueled by cost efficiency, cutting-edge ...
Letter: How Indonesia’s nickel boom avoids Opec curse
Without sustainability, resource-rich nations will face a curse: economic volatility and worsening inequality. Just as oil dependence led to price shocks and social disparities, Indonesia must ensure ...